Apoptosis and HIV infection: About molecules and genes

被引:37
作者
Cossarizza, Andrea [1 ,2 ]
机构
[1] Univ Modena, Dept Biomed Sci, Chair Immunol, I-41100 Modena, Italy
[2] Reggio Emilia Sch Med, I-41100 Modena, Italy
关键词
D O I
10.2174/138161208783413293
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
During the evolution, the immune system has developed several strategies to fight viral infections. Apoptosis, autophagy and necrosis are different types of cell death that play a main role in the interactions between infective agents and the host, since they are often important defence mechanisms that have to avoid the spreading of the infection. In turn, viruses have evolved numerous ways to evade the host immune system by influencing the behaviour and functionality of several components. HIV infects and kills CD4+ T helper lymphocytes, preferentially those that are antigen-specific, but also encodes proteins with apoptotic capacities, including gp120, gp160, Tat, Nef, Vpr, Vpu, Vif and, last but not least, the viral protease. This latter protein can kill infected and uninfected lymphocytes through the action of several host molecules, mainly members of the tumor necrosis factor family, or via the mitochondrial apoptotic pathway. The proinflammatory state that is characteristic of both the acute and chronic phase of HIV infection facilitates cell death, and is an additional cause of immune damage. Potent antiretroviral drugs that are largely use in therapy can reduce apoptosis by different mechanisms, that not only include the diminished production of the virus by infected cells and the subsequent reduction of inflammation, but also a direct action on the viral protease. The role of the host genetic background is finally crucial in understanding the process of cell death in HIV infection.
引用
收藏
页码:237 / 244
页数:8
相关论文
共 143 条
[51]   HIV-1 tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: A potential molecular mechanism to escape TRAIL cytotoxicity [J].
Gibellini, D ;
Re, MC ;
Ponti, C ;
Vitone, F ;
Bon, I ;
Fabbri, G ;
Di Iasio, MG ;
Zauli, G .
JOURNAL OF CELLULAR PHYSIOLOGY, 2005, 203 (03) :547-556
[52]   PNEUMOCYSTIS-CARINII PNEUMONIA AND MUCOSAL CANDIDIASIS IN PREVIOUSLY HEALTHY HOMOSEXUAL MEN - EVIDENCE OF A NEW ACQUIRED CELLULAR IMMUNODEFICIENCY [J].
GOTTLIEB, MS ;
SCHROFF, R ;
SCHANKER, HM ;
WEISMAN, JD ;
FAN, PT ;
WOLF, RA ;
SAXON, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (24) :1425-1431
[53]   Apoptosis and the CD95 system in HIV disease: impact of highly active anti-retroviral therapy (HAART) [J].
Gougeon, ML ;
Lecoeur, H ;
Sasaki, Y .
IMMUNOLOGY LETTERS, 1999, 66 (1-3) :97-103
[54]   Autophagy and cell death [J].
Gozuacik, Devrim ;
Kimchi, Adi .
CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY, VOL 78, 2007, 78 :217-245
[55]   Spontaneous and anti-Fas-induced apoptosis in lymphocytes from HIV-infected patients undergoing highly active anti-retroviral therapy [J].
Grelli, S ;
Campagna, S ;
Lichtner, M ;
Ricci, G ;
Vella, S ;
Vullo, V ;
Montella, F ;
Di Fabio, S ;
Favalli, C ;
Mastino, A ;
Macchi, B .
AIDS, 2000, 14 (08) :939-949
[56]   ACTIVATION-INDUCED DEATH BY APOPTOSIS IN CD4+ T-CELLS FROM HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED ASYMPTOMATIC INDIVIDUALS [J].
GROUX, H ;
TORPIER, G ;
MONTE, D ;
MOUTON, Y ;
CAPRON, A ;
AMEISEN, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (02) :331-340
[57]   Immunogenetics of CD4 lymphocyte count recovery during antiretroviral therapy: An AIDS clinical trials group study [J].
Haas, David W. ;
Geraghty, Daniel E. ;
Andersen, Janet ;
Mar, Jessica ;
Motsinger, Alison A. ;
D'Aquila, Richard T. ;
Unutmaz, Derya ;
Benson, Constance A. ;
Ritchie, Marylyn D. ;
Landay, Alan .
JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (08) :1098-1107
[58]  
HAAS DW, 2006, HIV AIDS REP, V3, P53
[59]   Treatment for adult HIV infection - 2006 recommendations of the International AIDS Society-USA panel [J].
Hammer, Scott M. ;
Saag, Michael S. ;
Schechter, Mauro ;
Montaner, Julio S. G. ;
Schooley, Robert T. ;
Jacobsen, Donna M. ;
Thompson, Melanie A. ;
Carpenter, Charles C. J. ;
Fischl, Margaret A. ;
Gazzard, Brian G. ;
Gatell, Jose M. ;
Hirsch, Martin S. ;
Katzenstein, David A. ;
Richman, Douglas D. ;
Vella, Stefano ;
Yeni, Patrick G. ;
Volberding, Paul A. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (07) :827-843
[60]   A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less [J].
Hammer, SM ;
Squires, KE ;
Hughes, MD ;
Grimes, JM ;
Demeter, LM ;
Currier, JS ;
Eron, JJ ;
Feinberg, JE ;
Balfour, HH ;
Dayton, LR ;
Chodakewitz, JA ;
Fischl, MA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :725-733